154 related articles for article (PubMed ID: 38230712)
1. Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population.
Liu Y; Jun H; Becker A; Wallick C; Mattke S
J Prev Alzheimers Dis; 2024; 11(1):7-12. PubMed ID: 38230712
[TBL] [Abstract][Full Text] [Related]
2. Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis.
Mattke S; Jun H; Chen E; Liu Y; Becker A; Wallick C
Alzheimers Res Ther; 2023 Jul; 15(1):128. PubMed ID: 37481563
[TBL] [Abstract][Full Text] [Related]
3. One-Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort Study.
Fowler NR; Campbell NL; Pohl GM; Munsie LM; Kirson NY; Desai U; Trieschman EJ; Meiselbach MK; Andrews JS; Boustani MA
J Am Geriatr Soc; 2018 May; 66(5):969-975. PubMed ID: 29608782
[TBL] [Abstract][Full Text] [Related]
4. Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis.
Lin PJ; Zhong Y; Fillit HM; Chen E; Neumann PJ
J Am Geriatr Soc; 2016 Aug; 64(8):1549-57. PubMed ID: 27295430
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Economic Assessment in Early-Stage Dementia by Severity and Amyloid-β Status: A 5-Year Retrospective Claims Study of GERAS-US Patients.
Chandler J; Kubisiak J
J Alzheimers Dis; 2023; 91(2):753-765. PubMed ID: 36502319
[TBL] [Abstract][Full Text] [Related]
6. Identification of Dementia in Recent Medicare Claims Data, Compared With Rigorous Clinical Assessments.
Grodstein F; Chang CH; Capuano AW; Power MC; Marquez DX; Barnes LL; Bennett DA; James BD; Bynum JPW
J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1272-1278. PubMed ID: 34919685
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of dementia and mild cognitive impairment before incarceration.
Kuffel RL; Byers AL; Williams B; Fortinsky R; Li Y; Ruderman MA; Barry LC
J Am Geriatr Soc; 2022 Jun; 70(6):1792-1799. PubMed ID: 35212389
[TBL] [Abstract][Full Text] [Related]
8. Identification of cognitively impaired patients at risk for development of Alzheimer's disease dementia: an analysis of US Medicare claims data.
Potashman M; Parcher B; Zhou J; Hou Q; Stefanacci R
Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):773-786. PubMed ID: 35196953
[TBL] [Abstract][Full Text] [Related]
9. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
Rabinovici GD; Gatsonis C; Apgar C; Chaudhary K; Gareen I; Hanna L; Hendrix J; Hillner BE; Olson C; Lesman-Segev OH; Romanoff J; Siegel BA; Whitmer RA; Carrillo MC
JAMA; 2019 Apr; 321(13):1286-1294. PubMed ID: 30938796
[TBL] [Abstract][Full Text] [Related]
10. 2022 Alzheimer's disease facts and figures.
Alzheimers Dement; 2022 Apr; 18(4):700-789. PubMed ID: 35289055
[TBL] [Abstract][Full Text] [Related]
11. A clinical index to predict progression from mild cognitive impairment to dementia due to Alzheimer's disease.
Lee SJ; Ritchie CS; Yaffe K; Stijacic Cenzer I; Barnes DE
PLoS One; 2014; 9(12):e113535. PubMed ID: 25486250
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer screening among Medicare Advantage enrollees with dementia.
Raver E; Xu WY; Jung J; Lee S
BMC Health Serv Res; 2024 Mar; 24(1):283. PubMed ID: 38443911
[TBL] [Abstract][Full Text] [Related]
13. Primary care detection of cognitive impairment leveraging health and consumer technologies in underserved US communities: protocol for a pragmatic randomised controlled trial of the MyCog paradigm.
Lovett R; Bonham M; Yoshino Benavente J; Hosseinian Z; Byrne GJ; Varela Diaz M; Bass M; Yao L; Adin-Cristian A; Batio S; Kim M; Sluis A; Moran M; Buchanan DR; Hunt J; Young SR; Gershon R; Nowinski C; Wolf M
BMJ Open; 2023 Oct; 13(10):e080101. PubMed ID: 37852774
[TBL] [Abstract][Full Text] [Related]
14. Identification of Dementia in Medicare Claims Compared to Rigorous Clinical Assessments in African Americans.
Grodstein F; James BD; Chen Y; Capuano AW; Power MC; Bennett DA; Bynum JPW; Barnes LL
J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37776149
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and incidence of depressive symptoms and diagnosis of depression as associated with elevated amyloid among Medicare beneficiaries with cognitive impairment.
Bélanger E; Jutkowitz E; Shewmaker P; Van Houtven CH; Burke JR; Plassman BL; Shepherd-Banigan M; Couch E; Mills C; Wetle TT
J Affect Disord; 2023 Aug; 334():293-296. PubMed ID: 37150216
[TBL] [Abstract][Full Text] [Related]
16. Validation of Self-Reported Cancer Diagnoses by Respondent Cognitive Status in the U.S. Health and Retirement Study.
Mullins MA; Kabeto M; Wallner LP; Kobayashi LC
J Gerontol A Biol Sci Med Sci; 2023 Jul; 78(7):1239-1245. PubMed ID: 36583244
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.
Brunton S; Pruzin JJ; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
Postgrad Med; 2023 Jun; 135(5):530-538. PubMed ID: 37219410
[TBL] [Abstract][Full Text] [Related]
18. Digital Clock and Recall is superior to the Mini-Mental State Examination for the detection of mild cognitive impairment and mild dementia.
Jannati A; Toro-Serey C; Gomes-Osman J; Banks R; Ciesla M; Showalter J; Bates D; Tobyne S; Pascual-Leone A
Alzheimers Res Ther; 2024 Jan; 16(1):2. PubMed ID: 38167251
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
